Leukoreduced blood transfusion does not increase circulating soluble markers of inflammation: A randomized controlled trial

Transfusion

Volumn 54, Issue 10, 2014, Pages 2404-2411

  Jiwaji, Zoeb ^a   Nunn, Kieran P ^a   Conway Morris, Andrew ^a   Simpson, A John ^b   Wyncoll, Duncan ^c   Rossi, Adriano G ^a   Walsh, Timothy S ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; L SELECTIN; LEUKOCYTE ELASTASE; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE TRANSFUSION; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; INFLAMMATION; INTENSIVE CARE UNIT; LEUKAPHERESIS; LEUKOCYTE ACTIVATION; LEUKOREDUCED RED BLOOD CELL TRANSFUSION; MAJOR CLINICAL STUDY; MALE; MEDIATOR; MIDDLE AGED; MULTICENTER STUDY; PLASMA; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; UNITED KINGDOM; BLOOD; BLOOD STORAGE; CLINICAL TRIAL;

ACUTE-PHASE REACTION; AGED; BIOLOGICAL MARKERS; BLOOD PRESERVATION; CRITICAL ILLNESS; CYTOKINES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; INFLAMMATION; LEUKAPHERESIS; MALE; MIDDLE AGED;

EID: 84908071633     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12669     Document Type: Article

References (34)

1. Corwin HL, Gettinger A, Pearl RG,. The CRIT study: anaemia and blood transfusion in the critically ill-current clinical practice in the United States. Crit Care Med 2004; 32: 39-52.
2. Walsh TS, Lee RJ, Maciver C, et al. Anaemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice. Intensive Care Med 2006; 32: 100-109.
3. Marik P, Corwin H,. Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. Crit Care Med 2008; 36: 2667-2674.
4. Vincent JL, Sakr Y, Sprung C, et al. Are blood transfusions associated with greater mortality rates? Results of the Sepsis Occurrence in Acutely Ill Patients study. Anesthesiology 2008; 108: 31-39.
5. Walsh TS,. Red cell transfusion triggers in critically ill patients: time for some new TRICCs? Crit Care 2010; 14: 170.
6. Carson JL, Terrin ML, Noveck H, et al.; FOCUS Investigators. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462.
7. Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery The TRACS randomized controlled trial. JAMA 2010; 304: 1559-1567.
8. Hebert PC, Wells G, Blajchman MA, et al. A multicentre, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med 1999; 340: 409-417.
9. Lacroix J, Hebert PC, Hutchison JS, et al. Transfusion strategies for patients in paediatric intensive care units. N Engl J Med 2007; 356: 1609-1619.
10. Vincent JL, Baron JF, Reinhart K, et al. Anaemia and blood transfusion in critically ill patients. JAMA 2002; 288: 1499-1507.
11. Bilgin YM, van de Watering LM, Versteegh MI, et al. Effects of allogeneic leukocytes in blood transfusions during cardiac surgery on inflammatory mediators and postoperative complications. Crit Care Med 2010; 38: 546-552.
12. Fransen E, Maessen J, Dentener M, et al. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest 1999; 116: 1233-1239.
13. McMichael MA, Smith SA, Galligan A, et al. Effect of leukoreduction on transfusion-induced inflammation in dogs. J Vet Intern Med 2010; 24: 1131-1137.
14. Bordin JO, Heddle NM, Blajchman MA,. Biologic effects of leukocytes present in transfused cellular blood products. Blood 1994; 84: 1703-1721.
15. Van de Watering LM, Hermans J, Houbiers JG, et al. Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial. Circulation 1998; 97: 562-568.
16. Baker CH, Wilmoth FR, Sutton ET,. Reduced RBC versus plasma microvascular flow due to endotoxin. Circ Shock 1986; 20: 127-139.
17. Hod EA, Zhang N, Sokol SA, et al. Transfusion of red blood cells after prolonged storage produced harmful effects that are mediated by iron and inflammation. Blood 2010; 115: 4284-4292.
18. Roberson RS, Lockhart E, Shapiro NI, et al. Impact of transfusion of autologous 7-versus 42-day-old AS-3 red blood cells on tissue oxygenation and the microcirculation in healthy volunteers. Transfusion 2012; 52: 2459-2464.
19. Langenfeld JE, Livingston DH, Machiedo GW,. Red cell deformability is an early indicator of infection. Surgery 1991; 110: 398-404.
20. Hebert PC, Fergusson D, Blajchman MA, et al. Clinical outcomes following institution of the Canadian universal leukoreduction program for red blood cell transfusions. JAMA 2003; 289: 1941-1949.
21. Weisbach V, Wanke C, Zingsem J, et al. Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates. Vox Sang 1999; 76: 100-106.
22. Izbicki G, Rudensky B, Na'amad M, et al. Transfusion-related leukocytosis in critically ill patients. Crit Care Med 2004; 32: 439-442.
23. Walsh TS, Boyd J, Watson D, et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit Care Med 2013; 41: 2354-2363.
24. Bickel M,. The role of interleukin-8 in inflammation and mechanisms of regulation. J Periodontol 1993; 64 (Suppl): 456-460.
25. Harada A, Sekido N, Akahoshi T, et al. Essential involvement of interleukin-8 (IL-8) in acute inflammation. J Leukoc Biol 1994; 56: 559-564.
26. Darbonne WC, Rice GC, Mohler MA, et al. Red blood cells are a sink for interleukin 8, a leukocyte chemotaxin. J Clin Invest 1991; 88: 1362-1369.
27. Avall A, Hyllner M, Bengtson JP, et al. Postoperative inflammatory response after autologous and allogenic blood transfusion. Anesthesiology 1997; 87: 511-516.
28. Lee JS, Sperry JL, Ochoa JB, et al. Persistence of elevated plasma CXCL8 concentrations following red blood cell transfusion in a trauma cohort. Shock 2012; 37: 373-377.
29. Ishijima N, Suzuki H,. Blood transfusion and postoperative serum interleukin-6 levels in colorectal cancer patients. Hepatogastroenterology 1998; 45: 1011-1013.
30. Leal-Noval SR, Munoz-Gomez M, Arellano V, et al. Influence of red blood cell transfusion on CD4+ T-helper cells immune response in patients undergoing cardiac surgery. J Surg Res 2010; 164: 43-49.
31. Baumgartner JM, Nydam TL, Clarke JH, et al. Red blood cell supernatant potentiates LPS-induced proinflammatory cytokine response from peripheral blood mononuclear cells. J Interferon Cytokine Res 2009; 29: 333-338.
32. Shanwell A, Kristiansson M, Remberger M, et al. Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction. Transfusion 1997; 37: 678-684.
33. Yazdanbakhsh K, Bao W, Zhong H,. Immunoregulatory effects of stored red blood cells. ASH Education Book. Hematology Am Soc Hematol Educ Program 2011; 2011: 466-469.
34. Stack G, Baril L, Napychank P, et al. Cytokine generation in stored, white cell-reduced, and bacterially contaminated units of red cells. Transfusion 1995; 35: 199-203.